HomeDoxorubicin HydrochlorideDoxorubicin Hydrochloride + St Johns Wort

Does Doxorubicin Hydrochloride Interact with St Johns Wort?

Doxorubicin Hydrochloride and St Johns Wort have a major drug interaction according to U.S. FDA drug labeling data. CYP3A4 inducer that may decrease doxorubicin concentration and clinical effect. The mechanism involves cyp3a4 induction. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.

Severity
Major
Management
Close medical supervision required
Data Source
U.S. FDA via OpenFDA

How This Interaction Works

The interaction between Doxorubicin Hydrochloride and St Johns Wort occurs because cyp3a4 induction. Clinically, this means cyp3a4 inducer that may decrease doxorubicin concentration and clinical effect. This is classified as a major interaction, meaning it could cause serious harm if not properly managed. Your healthcare provider may need to adjust dosages, substitute one medication, or increase monitoring frequency.

What To Tell Your Doctor or Pharmacist

If you are taking Doxorubicin Hydrochloride and your doctor is considering prescribing St Johns Wort (or vice versa), make sure to:

  • Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
  • Ask whether the benefits of combining these medications outweigh the risks for your specific situation
  • Ask what symptoms to watch for that would indicate the interaction is causing problems
  • Ask how frequently you should be monitored while these are co-prescribed
  • Ask whether any dosage adjustments are needed
  • Never stop or change either medication without first consulting your healthcare provider
💊 Doxorubicin Hydrochloride(Doxorubicin Hydrochloride)+💊 St Johns Wort

Severity & Interaction Details

⚠️
major
Use with caution — major interaction
Serious risk of clinically significant harm. Generally avoid; if used, monitor closely.
Severity scale
MinorContra
On record
Yes
Drug A class
Drug B class
Source
NLP:doxorubicin hydrochloride

What this means in plain English

CYP3A4 inducer that may decrease doxorubicin concentration and clinical effect.

What the FDA label says

"CYP3A4 induction"

📖 Source: NLP:doxorubicin hydrochloride

Share this result:XFacebookWhatsAppReddit
Add more drugs
Check Doxorubicin Hydrochloride and St Johns Wort against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine. For informational purposes only. Always consult your pharmacist or physician.